Digital Biomarkers – The Future of Precision Medicine
Health Advances
JULY 21, 2022
Precision Medicine (PM) has revolutionized oncology care, enabled by in vitro diagnostics (IVDs) that started with the approval of HercepTest in 1998 to identify patients with overexpression of HER2 for treatment with the targeted therapy Herceptin. Cardiology: Daytime physical activity in Congestive Heart Failure (CHF).
Let's personalize your content